Literature DB >> 23264798

Hummingbird sign in progressive supranuclear palsy disease.

Sanjay Pandey1.   

Abstract

Progressive supranuclear palsy (PSP) is characterized by slowness, rigidity, bradykinesia, repeated falls, downgaze limitation and dementia. Midbrain atrophy on magnetic resonance imaging is highly suggestive of PSP and is described as "hummingbird sign". This sign is very helpful in differentiating PSP patients from those with Parkinson's disease.We hereby report a 72-year-old female case of PSP primarily diagnosed with Parkinson's disease.

Entities:  

Keywords:  Hummingbird Sign; Midbrain; Progressive Supranuclear Palsy

Year:  2012        PMID: 23264798      PMCID: PMC3525042     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


INTRODUCTION

Progressive supranuclear palsy (PSP) is a neurodegenerative condition. It is an important differential diagnosis of Parkinson's disease (PD). Magnetic resonance imaging (MRI) in PSP patients may reveal significant midbrain atrophy with sparing of pons known as “hummingbird” sign.

CASE

A 72 year-old lady with gradually progressive history of slowness, frequent falls, rigidity and forgetfulness for 2 years was referred to us. She was initially diagnosed as a case of Parkinson's disease and was thus treated with levodopa/carbidopa for 3 months. She did not show any improvements in her symptoms and was referred to our hospital. On examination, she was having predominantly frontal lobe dysfunctions in the form of repetitive failure to perform executive function. She also had difficulty in calculation and recent memory. She had marked limitation in downgaze with slowing of horizontal saccades. She had foot dystonia and rigidity in all 4 limbs including neck and trunk. Motor power was normal and deep tendon reflexes were within normal limit. Her gait was slow with lack of arm swing on both sides and tendency to fall backward. Due to early onset of falls, dementia, predominant parkinsonian features and poor response to levodopa/carbidopa, a diagnosis of PSP was made. MRI of brain was conducted to rule out secondary causes of Parkinson's disease. MRI was suggestive of predominant atrophy of midbrain and preservation of pons and medulla (Figure 1).
Figure 1

A. Sagittal section of brain MRI in a PSP patient showing midbrain atrophy with preservation of pons (below black line) known as “hummingbird” sign

B. Sagittal section of brain MRI in a normal person (for comparison)

A. Sagittal section of brain MRI in a PSP patient showing midbrain atrophy with preservation of pons (below black line) known as “hummingbird” sign B. Sagittal section of brain MRI in a normal person (for comparison)

DISCUSSION

Prominent midbrain atrophy with no pontine atrophy in PSP patients has been referred to as “hummingbird” or “penguin” sign. This sign has been found to be quite useful in differentiating PSP from PD and multisystem atrophy (MSA).[12] This sign is best seen in midsagittal image showing flat and concave contour of midbrain. It also suggests rostral interstitial nucleus of medial longitudinal fasciculus involvement in PSP.[34] In one study, abnormal superior profile of midbrain has been found to be more helpful in differentiation PSP from PD patients.[5] Maximal diameter of midbrain in midsagittal plane has been compared in PSP, PD and MSA patients. It has been reported to be quite useful in diagnosing PSP patients. Magnetic resonance parkinsonism index, defined as the ratio of midbrain area to pons area, is another helpful way in diagnosis of PSP patients.[6]
  6 in total

1.  Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy.

Authors:  Klaus Gröschel; Andreas Kastrup; Irene Litvan; Jörg B Schulz
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

2.  Teaching NeuroImages: "Penguin" or "hummingbird" sign and midbrain atrophy in progressive supranuclear palsy.

Authors:  Jerome J Graber; Robert Staudinger
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

Review 3.  Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.

Authors:  Daniela Berg; Jonathan D Steinberger; C Warren Olanow; Thomas P Naidich; Tarek A Yousry
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Study of the rostral midbrain atrophy in progressive supranuclear palsy.

Authors:  Naoko Kato; Kimihito Arai; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

5.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.

Authors:  Andrea Righini; Angelo Antonini; Roberta De Notaris; Elena Bianchini; Nicoletta Meucci; Giorgio Sacilotto; Margherita Canesi; Danilo De Gaspari; Fabio Triulzi; Gianni Pezzoli
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

6.  MR imaging of brainstem atrophy in progressive supranuclear palsy.

Authors:  Jerzy Slowinski; Akiko Imamura; Ryan J Uitti; Robert A Pooley; Audrey J Strongosky; Dennis W Dickson; Daniel F Broderick; Zbigniew K Wszolek
Journal:  J Neurol       Date:  2007-12-19       Impact factor: 4.849

  6 in total
  1 in total

1.  α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.

Authors:  Ildefonso Rodríguez-Leyva; Ana Laura Calderón-Garcidueñas; María E Jiménez-Capdeville; Ana Arely Rentería-Palomo; Héctor Gerardo Hernandez-Rodriguez; Rodrigo Valdés-Rodríguez; Cornelia Fuentes-Ahumada; Bertha Torres-Álvarez; Julio Sepúlveda-Saavedra; Adolfo Soto-Domínguez; Martha E Santoyo; José Ildefonso Rodriguez-Moreno; Juan Pablo Castanedo-Cázares
Journal:  Ann Clin Transl Neurol       Date:  2014-07-01       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.